Information
Category : Information
- Information
Our Operating Officer & CSO, Tasuku Ishida, to Deliver an Invited Lecture at 3rd Targeted Protein Degradation Conference in Japan
- Information
Article on the Provision of Elix Discovery™ to Eisai Featured in FirstWord Pharma and AI BRIEF
- Information
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in BioPharmaTrend, AI BRIEF, and eCommerceNews
- Information
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in The Nikkei Biotech ONLINE, Nikkan Kogyo Shimbun Digital Edition, Biz/Zine, and AnswersNews
- Information
Our Application Scientist, Takahiro Inoue, to Participate as a Speaker in the 29th Tutorial Hosted by the Conference on Biomolecular Screenology (Online)
- Information
Our CEO, Shinya Yuki, to Deliver a Presentation at FJS 2025
- Information
Article on Partnership with PRISM BioLab Featured in Nikkei Biotech ONLINE
- Information
Article on Partnership with PRISM BioLab Featured in Nikkei